Anti-IFNg Antibody (Fontolizumab)
Catalog No.
F1206
Anti-IFNg Antibody (Fontolizumab)
Featured Products
Fontolizumab (HuZAF) is a humanized monoclonal anti-IFN-gamma antibody. Fontolizumab is an immunosuppressant. Fontolizumab is used in the research of Crohn's disease.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
326859-36-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
HuZAF, flintozumab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P01579
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human IFN γ His at 2 ug/mL can bind Anti-IFNg Antibody (Fontolizumab)
IFNg
Please avoid freeze-thaw cycles.